Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics will participate in three September healthcare investor conferences: Cantor Global Healthcare on September 9, Wells Fargo 21st Annual Healthcare on September 10, and Morgan Stanley 24th Annual Global Healthcare on September 15, with management holding investor meetings at each. At the Morgan Stanley conference, CFO Scott Giacobello and CSO David Dornan will join a fireside chat on September 15 at 1:05 PM ET, webcast live with a replay available for approximately 30 days. The release contains no new financial or clinical data; it recaps the existing ADC pipeline (HWK-007, HWK-016, HWK-206) in-licensed from WuXi Biologics.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.